isoxazoles has been researched along with trolamine salicylate in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.24) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 16 (55.17) | 29.6817 |
| 2010's | 5 (17.24) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| DiPasquale, G; Gingold, J; Rassaert, C; Schwartz, E; Welaj, P | 1 |
| Diamantis, W; Ludwig, BJ; Sofia, RD | 1 |
| Hambleton, P; McMahon, S | 1 |
| Hirschelmann, R; Schade, R | 1 |
| Buyniski, JP; Gylys, JA; Pasternak, RD; Siminoff, P; Wadopian, NS; Wright, RN | 1 |
| Bartlett, RR; Schleyerbach, R | 1 |
| Brauer, R; Henzgen, S; Katenkamp, D; Petrow, PK; Thoss, K | 1 |
| FitzGerald, GA | 1 |
| Gotta, AW | 1 |
| Ormrod, D; Wagstaff, AJ; Wellington, K | 1 |
| Bandyopadhyay, D | 1 |
| Magari, K; Miyata, S; Mutoh, S; Nishigaki, F; Ohkubo, Y | 1 |
| Braun, J; Haibel, H; Rudwaleit, M; Sieper, J | 1 |
| Topol, EJ | 1 |
| Okie, S | 1 |
| Lange, U; Müller-Ladner, U; Piegsa, M; Strunk, J | 1 |
| Caruso, A; Ferri, C; Giuggioli, D; Sebastiani, M; Vesprini, E | 1 |
| Tabrizchi, R | 1 |
| Evans, SJ; Lawson, TM; Siebert, S; Webb, D | 1 |
| Li, SG | 1 |
| Beuers, U; Budenhofer, U; Kremer, AE; Rust, C | 1 |
| Collins, D; Duke, O; Kaul, A; Kiely, PD; O'Reilly, DT; Slack, RK; Walmsley, J | 1 |
| Cao, GQ; Chakrabarti, PP; Henkle, B; Hsieh, F; Lee, MR; Middleton, S; Pettus, LH; Plant, MH; Powers, DA; Rzasa, RM; Saris, CJ; Sham, K; Sherman, L; Syed, R; Tasker, AS; Tudor, Y; Wong, LM; Wurz, RP; Xu, S; Yu, V; Zhang, D | 1 |
| Baker, TA; Colopy, SA; Muir, P | 1 |
| Haroon, M; O'Gradaigh, D | 1 |
| Artifoni, M; Puéchal, X | 1 |
| Cortés-Hernández, J; Egri, N; Ordi-Ros, J; Vilardell-Tarrés, M | 1 |
| Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS | 1 |
| Lucena, F; McDougall, JJ | 1 |
3 review(s) available for isoxazoles and trolamine salicylate
| Article | Year |
|---|---|
Valdecoxib (Pharmacia).
Topics: Arthritis; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drugs, Investigational; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Sulfonamides; Treatment Outcome | 2002 |
Valdecoxib.
Topics: Arthritis; Clinical Trials as Topic; Dysmenorrhea; Female; Humans; Isoxazoles; Pain; Sulfonamides | 2002 |
How to treat refractory arthritis in lupus?
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis; Azathioprine; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoconjugates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2012 |
2 trial(s) available for isoxazoles and trolamine salicylate
| Article | Year |
|---|---|
Six months open label trial of leflunomide in active ankylosing spondylitis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Patient Dropouts; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome | 2005 |
Efficacy and safety of combining intra-articular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory monoarthritis.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Drug Therapy, Combination; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Injections, Intra-Articular; Isoxazoles; Knee Joint; Leflunomide; Male; Methylprednisolone; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Secondary Prevention; Tumor Necrosis Factor-alpha | 2010 |
24 other study(ies) available for isoxazoles and trolamine salicylate
| Article | Year |
|---|---|
Effects of multiple treatments of isoxicam on organ weights and serum SGPT, AP, and BUN in adjuvant-induced polyarthritic rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Arthritis; Arthritis, Experimental; Blood Urea Nitrogen; Isoxazoles; Male; Organ Size; Oxazoles; Piroxicam; Rats; Thiazines | 1978 |
Comparative anti-inflammatory, analgesic, and antipyretic activities of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one and 5-chlorosalicylic acid in rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Body Temperature; Edema; Isoxazoles; Male; Oxazines; Oxazoles; Rats; Salicylates; Stomach Ulcer | 1975 |
Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Arthritis; Arthritis, Experimental; Cyclosporins; Freund's Adjuvant; Hypersensitivity, Delayed; Indomethacin; Isoxazoles; Kinetics; Leflunomide; Male; Mycobacterium; Propionates; Rats; Steroids | 1990 |
6-Sulfanilamidoindazole arthritis in rats: influence of the new anti-inflammatory agent CGP 28237 and of the immunomodulating compound HWA 486 on degree of arthritis and on acute phase reaction.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Indans; Indenes; Inflammation; Isoxazoles; Leflunomide; Oxazoles; Rats; Sulfanilamides | 1988 |
Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Cyclosporins; Hypersensitivity, Delayed; In Vitro Techniques; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxazoles; Rats; Rats, Inbred Lew | 1987 |
Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Cyclophosphamide; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxazoles; Radiography; Rats; Rats, Inbred Lew | 1985 |
Immunomodulation of rat antigen-induced arthritis by leflunomide alone and in combination with cyclosporin A.
Topics: Animals; Arthritis; Autoantibodies; Cyclosporine; Female; Immunosuppressive Agents; Isoxazoles; Leflunomide; Organ Size; Rats; Rats, Wistar; Serum Albumin, Bovine | 1996 |
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular System; Celecoxib; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Isoxazoles; Lactones; Male; Pyrazoles; Sulfonamides; Sulfones | 2002 |
Exfoliative dermatitis induced by leflunomide therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Dermatitis, Exfoliative; Diagnosis, Differential; Humans; Isoxazoles; Leflunomide; Male; Middle Aged | 2003 |
Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Marrow Cells; CD28 Antigens; CD3 Complex; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunosuppressive Agents; Inflammation; Isoxazoles; Leflunomide; Leukocytes; Leukocytes, Mononuclear; Lymphocyte Activation; Methotrexate; Mice; Neutrophils; Random Allocation; Rats; Rats, Inbred Lew; T-Lymphocytes; Tacrolimus; Time Factors | 2004 |
Arthritis medicines and cardiovascular events--"house of coxibs".
Topics: Adenoma; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Drug Approval; Humans; Isoxazoles; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration | 2005 |
Raising the safety bar--the FDA's coxib meeting.
Topics: Advertising; Advisory Committees; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Approval; Drug Industry; Drug Labeling; Humans; Isoxazoles; Lactones; Product Surveillance, Postmarketing; Pyrazoles; Sulfonamides; Sulfones; United States; United States Food and Drug Administration | 2005 |
Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.
Topics: Antibodies, Antinuclear; Arthritis; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Middle Aged; Polymyositis; Prednisolone | 2006 |
Successful treatment with leflunomide of arthritis in systemic sclerosis patients.
Topics: Adult; Antirheumatic Agents; Arthritis; Female; Humans; Isoxazoles; Leflunomide; Middle Aged; Scleroderma, Systemic | 2006 |
Coxibs: can this class of drugs survive?
Topics: Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Etoricoxib; Evidence-Based Medicine; Half-Life; Humans; Isoxazoles; Lactones; Patient Selection; Pyrazoles; Pyridines; Sulfonamides; Sulfones | 2005 |
Renal tubular acidosis associated with leflunomide.
Topics: Acidosis, Renal Tubular; Adult; Antirheumatic Agents; Arthritis; Female; Humans; Isoxazoles; Leflunomide | 2007 |
Clinical images: healing of sacroiliitis with leflunomide and sulfasalazine treatment.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Humans; Isoxazoles; Leflunomide; Male; Sacroiliac Joint; Sulfasalazine; Tomography, X-Ray Computed | 2008 |
[A 47-year-old dog breeder with chronic polyarthritis, weight loss and high fever].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Diagnosis, Differential; Disease Progression; Fever of Unknown Origin; Humans; Immunologic Deficiency Syndromes; Isoxazoles; Leflunomide; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Systemic Inflammatory Response Syndrome; Tropheryma; Weight Loss; Whipple Disease | 2008 |
Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged | 2008 |
3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Topics: Administration, Oral; Amines; Animals; Arthritis; Benzene; Crystallography, X-Ray; Disease Models, Animal; Humans; Isoxazoles; Mitogen-Activated Protein Kinase 14; Models, Molecular; Molecular Structure; Phthalazines; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship | 2008 |
Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Dog Diseases; Dogs; Female; Isoxazoles; Leflunomide; Male; Retrospective Studies | 2010 |
Etanercept in refractory lupus arthritis: An observational study.
Topics: Adult; Antirheumatic Agents; Arthritis; Autoantibodies; Cohort Studies; Etanercept; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Treatment Outcome | 2015 |
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders | 2016 |
Pain responses to protease-activated receptor-2 stimulation in the spinal cord of naïve and arthritic rats.
Topics: Animals; Arthritis; Dipeptides; Disease Models, Animal; Hyperalgesia; Isoxazoles; Male; Nociception; Pain Threshold; Rats, Wistar; Receptor, PAR-2; Spinal Cord | 2020 |